
Analgesics in Slovakia
Description
Analgesics in Slovakia
Demand for analgesics in Slovakia is expected to stabilise in 2024, following the sharp drop in retail volume across most subcategories in 2023. This contraction was driven in part by significant stockpiling of OTC analgesics at the end of 2022/early-2023, particularly in the paediatric segment, due to widespread shortages. Media coverage of the shortages, especially of key brands like Panadol and Nurofen, led to panic buying, exacerbating the problem. Many Slovaks bought large quantities of the...
Euromonitor International's Analgesics in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
25 Pages
- Analgesics in Slovakia
- Euromonitor International
- October 2024
- List Of Contents And Tables
- ANALGESICS IN SLOVAKIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Consumption of analgesics is expected to stabilise
- GSK’s Panadol brand is poised for recovery, while Nurofen could suffer from previous over-purchasing
- Brighter performance for topical analgesics/anaesthetic
- PROSPECTS AND OPPORTUNITIES
- Optimistic outlook for the coming years
- Manufacturers will focus on differentiation to stimulate demand
- Traditional pharmacies will remain dominant channel of distribution
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN SLOVAKIA
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2023-2024
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.